Acute lymphoblastic leukaemia first line - dasatinib - initial (induction and consolidation) authority application form (PB271)

Use this form to apply for initial (induction and consolidation) PBS-subsidised therapy with dasatinib in the first-line treatment of acute lymphoblastic leukaemia.

Page last updated: 1 January 2025.
QC 51325